.jpg)
Emilia Romagna (ITH5)
Innovation Performance Group (2019) : Moderate +
Total population (2019) 4,459,477
Population per km² (2017) 201
Proportion population older 65 year % 23,95%
Background
Emilia-Romagna is a region in the northeast of Italy comprising the historical regions of Emilia and Romagna, it has a population of 4.5 million. It is home to the University of Bologna, which was founded in 1088 and is the oldest university in the world.
The region has a focus on the emerging fields of regenerative and restorative medicine, as well as pharmaceutical and omics sciences and inclusive services and usable technologies for healthy living and active aging.
Emilia-Romagna is involved in a number of major initiatives in the field of personalised medicine including Hologene, Custom Implants, Italian Infrastructure for Regenerative Medicine, SUPER HPC and Big Data and Italian Biobanks network.
Is the region looking for international/European/interregional collaboration opportunities?
Yes - Identification of standard protocols to collect data and support on how to overcome the barriers about privacy regulation.
Membership status
Member ICPerMed? no
Mountain ? 27% is hilly and 25% mountainous
Member Euregha? yes
Adriatic-Ionian MacroRegion? yes
InnoStars Region? yes
Northern Sparsely Populated Area (NSPA)? no
PM region according EC? no
Baltic Sea MacroRegion? no
S3MedTech region? yes
Danube MacroRegion? no
S3P4PM region? yes
Alpine MacroRegion? no
Regions4PM region? yes
ERAPerMed? no
Central Europe? yes
MedTech4Europe? no
Council of European BioRegions (CEBR)? no
1M+Genome initiative? countrylevel member
European Regions Research & Innovation Network (ERRIN)? yes
Vanguard Initiative? yes
S3ClusSport member? yes
Policy documents
National level: SNSI - National smart specialization
National level: ALISEI applied life science national cluster strategic plan
Topics covered by policies : Medical research and innovation (-omics, biomarkers, diagnostics, etc.); Specific disease related research;Prediction and prevention; ICT/genomics, health, lifestyle data(infrastructure); Electronic and mobile health solutions; Public awareness, patient participation with respect to Personalised Medicine/Personalised Health
Which disease related research: - Rare diseases, Oncologic, Orthopeadics
Funding programmes or other support measures:
NACE Personalised Medicine/Personalised Health related to Research and Innovation objectives:
C.20 - Chemicals and chemical products; C.21 - Basic pharmaceutical products and pharmaceutical preparations C.28 - Machinery and equipment n.e.c.; J.62 - Computer programming, consultancy and related activities; Q - Human health and social work activities; Q.88 - Social work activities without accommodation; M - Professional, scientific and technical activities; P - Education
Scientific domain NABS Personalised Medicine/Personalised Health related to Research and Innovation: NABS06 - Industrial production and technology; NABS07 - Health;NABS09 - Education; NABS12 - General advancement of knowledge: R&D financed from General University Funds (GUF); NABS13 - General advancement of knowledge: R&D financed from other sources than GUF; NABS99 - Total R&D appropriations
Policy objective Personalised Medicine/Personalised Healthrelated related to Research and Innovation objectives: D - Digital transformation; E.37 - Advanced manufacturing systems;E.38 - Advanced materials; E.40 - Micro/Nano-electronics; E.41 - Nanotechnology; G.46 - Ageing societies; G.49 - Public health & well-being; G.50 - Public safety & pandemics; H - Service innovation; I.54 - New organisational models & social relations that meet social needs; I.55 - New products or services that meet social needs; I.59 - Social innovation with regard to health, well-being & elder care
Policy document (RIS3): Yes
Policy document PM@RIS3: Yes
Major initiatives
Hologene 7 2.0
SUPER HPC and Big Data
BBMRI.it Italian Biobanks network
Collaboration with Piedmont Region
BIOGEN - Genetic Biobank
LTTA Biobank (Laboratory for Advanced Therapy Technologies)
Digital Innovation Hubs:
SMILE-DIH (Smart Manufacturing Innovation for Lean Excellence center - Digital Innovation Hub)
Is the region represented in: Horizon2020; Regional Smart Specialisation Strategy Platforms/Partnerships (RIS3); EIT Health/InnoStars/Regional Innovation Scheme (RIS); other?
BBMRI EUS3 Platform - Personalized Medicine
H2020 - SMEINST - Oncosmart - ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics
H2020- SMEINST- BIOFOSTE - Clinical validation of a BIOmarker panel For OSTEoarthritis diagnosis: BIOFOSTE
H2020 - SC1- ADIPOA2 - Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritis
Self evaluation
General perception of the implementation level of PM in the region - High
Rate of the need for developing and implementing PM in the region - High
Rate of the need for increasing support/funding for PM activities in the region - Very High
Rate of the need for increasing the capacity of PM skills in the region - High
Rate of the genomics literacy of the citizens in the region - Medium
Rate of the need for increasing interregional collaboration in PM - Medium
Memberships
European Regional and Local Health Authorities (EUREGHA)
European Regions Research and Innovation Network (ERRIN)
Image attribution
By TUBS - Own workThis SVG map includes elements that have been taken or adapted from this map: Italy location map.svg (by NordNordWest)., CC BY-SA 3.0,